Clinical Utility of Selinexor/Dexamethasone in Patients with Relapsed or Refractory Multiple Myeloma: A Review of Current Evidence and Patient Selection

Malandrakis P, Ntanasis-Stathopoulos I, Gavriatopoulou M, Terpos E

OncoTargets and Therapy 2020, 13:6405-6416

Published Date: 1 July 2020